New Formulation of FDA-Approved Drug Shows Encouraging Results for Treating a Common Itch Condition in Phase 2 Clinical Trial
New York, NY (PRWEB) February 09, 2023 -- Notalgia paresthetica—a nerve disorder characterized by a persistent itch in the upper back—is a common and